| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 3.18 Billion | USD 6.86 Billion | 8.9% | 2024 |
FrequentlyAsked Questions
The global erectile dysfunction drugs market is expected to grow due to rising prevalence of erectile dysfunction, increasing awareness and acceptance of treatment options, advancements in drug formulations, and the growing aging male population seeking effective solutions.
According to a study, the global erectile dysfunction drugs market size was worth around USD 3.18 Billion in 2024 and is expected to reach USD 6.86 Billion by 2034.
The global erectile dysfunction drugs market is expected to grow at a CAGR of 8.9% during the forecast period.
North America is expected to dominate the erectile dysfunction drugs market over the forecast period.
Leading players in the global erectile dysfunction drugs market include Eli Lilly & Co., Pfizer, Dong-A Pharmaceutical Co. Ltd, Bayer AG, Meda Pharmaceuticals, Vivus Inc., and Apricus Biosciences, among others.
The report explores crucial aspects of the erectile dysfunction drugs market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients